clinical trials

Health Tech By Casey Ross

Drug companies deliver a vote of confidence in adaptive trial for Covid-19

Pharma By Rebecca Ritzel

FDA pushes drug companies to include younger people in breast cancer drug trials 

Biotech By Kate Sheridan

Seres announces positive late-stage results for its microbe-based drug

First Opinion By Joseph S. Ross, Joanne Waldstreicher, and Harlan M. Krumholz

Sharing clinical trial data: lessons from the YODA Project

Pharmalot By Ed Silverman

Flawed trials supported half of recent approvals of cancer drugs in Europe, study says

First Opinion By Bobby Clark and Ronnie Tepp

Community engagement is key to clinical trial recruitment and diversity

First Opinion By Rebecca Li

Move clinical trial data sharing from an option to an imperative

First Opinion By Louise Aronson

A new NIH rule won’t be enough to make clinical research more inclusive

First Opinion By Jane L. Delgado and Edward Abrahams

Diversity in clinical trials defines good science and better medicine

First Opinion By Jeremy Farrar

It isn’t crazy to conduct an Ebola clinical trial in a war zone — it’s necessary

Pharmalot By Ed Silverman

Pharmalittle: Trump to require drug prices in ads; Europe cracks down on valsartan ingredients maker

First Opinion By Julia G. Brody

All study participants have a right to know their own results. My lab has been doing that for years

First Opinion By Jake LaPorte

Digital technologies hold the key to streamlining and improving clinical trials

First Opinion By Anne Poli

China isn’t yet ready to conduct clinical trials for the pharma industry

Lessons Learned By Megha Satyanarayana

Lessons Learned: This is how you take a public health degree to a startup and back to academia

Pharmalot By Ed Silverman

Millions in fines are adding up as clinical trial information goes unreported

Adam's Take By Adam Feuerstein

Marinus Pharma finds the biotech imitation game can only last so long

Biotech By Adam Feuerstein

Dermira discontinues development of acne drug after two late-stage trials fail

First Opinion By Howard M. Fillit

FDA’s updated standards remove an unnecessary barrier to testing Alzheimer’s drugs

In the Lab By Andrew Joseph

How well can you predict the outcome of clinical trials? Not as well as you may think

Health By Marisa Taylor — Kaiser Health News

Unregulated herpes experiments expose ‘black hole’ of accountability

Biotech By Adam Feuerstein

Nabriva novel antibiotic meets goals in late-stage bacterial pneumonia study

Business By Adam Feuerstein

Stakes are high as Alnylam awaits results from novel rare disease therapy

Business By Adam Feuerstein

5 things to know about Sage’s must-win drug trials in postpartum depression

Pharma By Adam Feuerstein

AstraZeneca immunotherapy study shows benefit for niche group of lung cancer patients